TY  - CONF
ID  - discovery10047475
PB  - Elsevier
T2  - 11th Annual UK Neuromuscular Translational Research Conference
CY  - Neuromuscular Disorders
KW  - Periodic Paralysis
KW  -  Channelopathy
KW  -  Hypokalaemic Periodic Paralysis
KW  -  CMAP
KW  -  Phase II
KW  -  Drug repurposing study
KW  -  Long exercise test
KW  -  Neurophysiology
KW  -  Outcome measure
KW  -  Treatment
TI  - RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure
AV  - public
Y1  - 2018/04//
EP  - S27
UR  - https://doi.org/10.1016/S0960-8966(18)30370-5
SN  - 0960-8966
A1  - Scalco, RS
A1  - Morrow, J
A1  - Manole, A
A1  - Skorupinska, I
A1  - Bellin, A
A1  - Ricciardi, F
A1  - Matthews, E
A1  - Hanna, M
A1  - Fialho, D
SP  - S27
VL  - 28
M2  - Cambridge
N1  - This version is the author accepted manuscript. For information on re-use, please refer to the publisher?s terms and conditions.
ER  -